Rep. Jonathan L. Jackson Buys Lam Research Corporation (NASDAQ:LRCX) Stock

Representative Jonathan L. Jackson (D-Illinois) recently bought shares of Lam Research Corporation (NASDAQ:LRCX). In a filing disclosed on September 23rd, the Representative disclosed that they had bought between $1,001 and $15,000 in Lam Research stock on August 13th. The trade occurred in the Representative’s “MORGAN STANLEY – ROLLOVER IRA” account.

Representative Jonathan L. Jackson also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Doximity (NASDAQ:DOCS) on 8/25/2025.
• Sold $1,001 – $15,000 in shares of International Business Machines (NYSE:IBM) on 8/13/2025.
• Sold $1,001 – $15,000 in shares of Fomento Economico Mexicano (NYSE:FMX) on 7/17/2025.
• Purchased $1,001 – $15,000 in shares of ARM (NASDAQ:ARM) on 7/17/2025.

Lam Research Price Performance

LRCX stock traded up $2.60 during trading on Tuesday, hitting $133.69. The company had a trading volume of 2,354,134 shares, compared to its average volume of 11,873,758. Lam Research Corporation has a fifty-two week low of $56.32 and a fifty-two week high of $134.21. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38. The company has a fifty day moving average price of $106.87 and a two-hundred day moving average price of $90.67. The company has a market cap of $168.59 billion, a P/E ratio of 32.13, a P/E/G ratio of 1.62 and a beta of 1.76.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, July 30th. The semiconductor company reported $1.33 EPS for the quarter, beating the consensus estimate of $1.21 by $0.12. The company had revenue of $5.17 billion for the quarter, compared to the consensus estimate of $4.99 billion. Lam Research had a net margin of 29.07% and a return on equity of 58.17%. The firm’s revenue for the quarter was up 33.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.03 EPS. Lam Research has set its Q1 2026 guidance at 1.100-1.300 EPS. Equities research analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, September 24th will be paid a $0.26 dividend. The ex-dividend date of this dividend is Wednesday, September 24th. This represents a $1.04 annualized dividend and a yield of 0.8%. This is a positive change from Lam Research’s previous quarterly dividend of $0.23. Lam Research’s payout ratio is presently 25.00%.

Analyst Ratings Changes

A number of equities analysts have commented on the company. UBS Group boosted their price objective on Lam Research from $95.00 to $120.00 and gave the stock a “buy” rating in a research note on Monday, July 21st. HSBC set a $127.00 price objective on Lam Research and gave the stock a “hold” rating in a research note on Tuesday. The Goldman Sachs Group assumed coverage on shares of Lam Research in a research report on Thursday, July 10th. They set a “buy” rating and a $115.00 price target on the stock. Argus upped their target price on shares of Lam Research from $105.00 to $120.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Finally, Raymond James Financial upped their target price on shares of Lam Research from $90.00 to $110.00 and gave the stock an “outperform” rating in a research report on Thursday, July 31st. Twenty-one investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $115.33.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Norges Bank acquired a new stake in shares of Lam Research during the second quarter worth about $1,894,585,000. Vanguard Group Inc. raised its holdings in shares of Lam Research by 6.9% in the first quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after purchasing an additional 8,364,375 shares during the last quarter. Nuveen LLC acquired a new stake in Lam Research in the 1st quarter valued at $604,344,000. JPMorgan Chase & Co. increased its stake in Lam Research by 14.4% in the 2nd quarter. JPMorgan Chase & Co. now owns 40,622,437 shares of the semiconductor company’s stock valued at $3,954,188,000 after buying an additional 5,102,589 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its position in shares of Lam Research by 99.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,739,221 shares of the semiconductor company’s stock valued at $417,242,000 after acquiring an additional 2,864,863 shares during the last quarter. Institutional investors and hedge funds own 84.61% of the company’s stock.

About Representative Jackson

Jonathan Jackson (Democratic Party) is a member of the U.S. House, representing Illinois’ 1st Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027.

Jackson (Democratic Party) is running for re-election to the U.S. House to represent Illinois’ 1st Congressional District. He declared candidacy for the 2026 election.

Jonathan Jackson was born in Chicago, Illinois. Jackson graduated from Whitney Young High School. He earned an M.B.A. from Northwestern University. Jackson’s career experience includes working as an investment analyst and an entrepreneur.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.